Valuation: Zynex Inc.

Market Cap 3.83M 3.31M 3.1M 2.83M 5.34M 365M 5.42M 36.33M 14.26M 183M 14.38M 14.06M 608M P/E 2023
40.3x
P/E 2024 89x
Enterprise Value 38.02M 32.92M 30.77M 28.12M 52.99M 3.63B 53.82M 361M 142M 1.81B 143M 140M 6.04B EV / Sales 2023
2.17x
EV / Sales 2024 1.5x
Free-Float
38.37%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 53 18/08/2025
Director of Finance/CFO 50 18/08/2025
General Counsel 53 18/08/2025
Director TitleAgeSince
Director/Board Member 50 26/03/2026
Director/Board Member 53 26/03/2026
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 1.69M
+0.96%+4.47%+30.16%+9.58% 220B
+2.25%+6.01%+4.39%-18.65% 144B
+3.85%+4.79%-16.32%+29.12% 134B
+2.33%+4.19%-51.08%-0.79% 71.46B
+2.57%+3.61%+17.46%+17.57% 51.71B
-0.86%+0.15%-15.64%-18.16% 50.84B
+1.88%+6.38%+29.75%+16.51% 41.23B
+1.21%+9.88%+46.43%+42.33% 39.95B
+1.63%+4.60%+1.31%+0.89% 32.42B
Average +1.58%+4.56%+5.16%+8.71% 87.22B
Weighted average by Cap. +1.89%+5.45%+5.93%+7.19%

Financials

2023 2024
Net sales 184M 160M 149M 136M 257M 17.58B 261M 1.75B 686M 8.79B 692M 677M 29.29B 192M 167M 156M 142M 268M 18.35B 272M 1.83B 716M 9.18B 722M 707M 30.57B
Net income 9.73M 8.42M 7.87M 7.2M 13.56M 928M 13.77M 92.34M 36.24M 464M 36.54M 35.75M 1.55B 2.99M 2.59M 2.42M 2.21M 4.17M 286M 4.24M 28.41M 11.15M 143M 11.24M 11M 476M
Net Debt 31.59M 27.35M 25.56M 23.36M 44.02M 3.01B 44.71M 300M 118M 1.51B 119M 116M 5.02B 34.19M 29.6M 27.67M 25.29M 47.65M 3.26B 48.4M 324M 127M 1.63B 128M 126M 5.43B
Logo Zynex Inc.
Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
Employees
-